Abiomed Inc (ABMD) - Financial and Strategic SWOT Analysis Review

June 2021 | 57 pages | ID: A433D1221DE2EN
GlobalData

Abstracts

Abiomed Inc (ABMD) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

• Business description – A detailed description of the company’s operations and business divisions.
• Corporate strategy – Analyst’s summarization of the company’s business strategy.
• SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
• Company history – Progression of key events associated with the company.
• Major products and services – A list of major products, services and brands of the company.
• Key competitors – A list of key competitors to the company.
• Key employees – A list of the key executives of the company.
• Executive biographies – A brief summary of the executives’ employment history.
• Key operational heads – A list of personnel heading key departments/functions.
• Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
• Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
• Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Abiomed Inc (Abiomed) develops, manufactures and markets novel technologies and is a provider of mechanical circulatory support devices that replace or assist the pumping function in a failing heart. The company’s heart support and recovery product portfolio include Impella heart pumps (catheter-based devices including micro heart pumps, expandable catheter pumps and axial flow pumps) and Breethe system (implantable cardiac and respiratory assist devices). Abiomed also offers online clinical support through Impella Connect, on-call assistance and on-site assistance for health workers in hospitals. The company sells its products through direct sales and distributors in South America, Europe, Asia and the Middle East. Abiomed is headquartered in Danvers, Massachusetts, the US.

Abiomed Inc Key Recent Developments

Jun 02,2021: Abiomed acquires catheter and controller developer preCARDIA
Apr 28,2021: Dr. Paula A. Johnson Joins Abiomed Board of Directors
Apr 08,2021: Abiomed Fourth Quarter Fiscal 2021 Earnings and Conference Call Notification
Mar 04,2021: MEDCERT enables the use of the single access procedure with Impella CP introducer sheaths in Europe
Feb 24,2021: Abiomed Chairman, President and CEO Michael R. Minogue named Chairman of AdvaMed Board of Directors

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

• The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

• The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

• Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.

• Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

• Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

Contents

SECTION 1 - ABOUT THE COMPANY

Abiomed Inc - Key Facts
Abiomed Inc - Key Employees
Abiomed Inc - Key Employee Biographies
Abiomed Inc - Major Products and Services
Abiomed Inc - History
Abiomed Inc - Company Statement
Abiomed Inc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries

SECTION 2 – COMPANY ANALYSIS

Company Overview
Abiomed Inc - Business Description
Product Category: Impella Product Revenue
Overview
Performance
Product Category: Service and Other Revenue
Overview
Performance
Geographical Segment: Europe
Performance
Geographical Segment: International
Performance
Geographical Segment: Japan
Performance
Geographical Segment: The US
Performance
R&D Overview
Abiomed Inc - Corporate Strategy
Abiomed Inc - SWOT Analysis
SWOT Analysis - Overview
Abiomed Inc - Strengths
Abiomed Inc - Weaknesses
Abiomed Inc - Opportunities
Abiomed Inc - Threats
Abiomed Inc - Key Competitors

SECTION 3 – COMPANY FINANCIAL RATIOS

Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts

SECTION 4 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES

Abiomed Inc, Medical Equipment, Deals By Year, 2015 to YTD 2021
Abiomed Inc, Medical Equipment, Deals By Type, 2015 to YTD 2021
Abiomed Inc, Recent Deals Summary

SECTION 5 – COMPANY’S RECENT DEVELOPMENTS

Apr 28, 2021: Dr. Paula A. Johnson Joins Abiomed Board of Directors
Apr 08, 2021: Abiomed Fourth Quarter Fiscal 2021 Earnings and Conference Call Notification
Mar 04, 2021: MEDCERT enables the use of the single access procedure with Impella CP introducer sheaths in Europe
Feb 24, 2021: Abiomed Chairman, President and CEO Michael R. Minogue named Chairman of AdvaMed Board of Directors
Feb 17, 2021: Abiomed to Present at Upcoming Investor Conferences
Feb 17, 2021: Abiomed Announces Appointment of Dr. Myron Rolle to Board of Directors
Jan 28, 2021: Abiomed announces Q3 FY 2021 record revenue of $232 million, up 5% year over year, with 31% operating margin
Jan 07, 2021: Abiomed continues to strengthen its intellectual property and already has more than 1,000 patents
Oct 29, 2020: Abiomed announces Q2 FY 2021 revenue of $210 million, Up 27% over Q1 FY 2021 and Up 2% over Q2 FY 2020 with 29.2% operating margin
Oct 15, 2020: Abiomed to host a virtual meeting to discuss new clinical data presented at TCT Connect

SECTION 6 – APPENDIX

Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List Of Tables

LIST OF TABLES

Abiomed Inc, Key Facts
Abiomed Inc, Key Employees
Abiomed Inc, Key Employee Biographies
Abiomed Inc, Major Products and Services
Abiomed Inc, History
Abiomed Inc, Subsidiaries
Abiomed Inc, Key Competitors
Abiomed Inc, Ratios based on current share price
Abiomed Inc, Annual Ratios
Abiomed Inc, Annual Ratios (Cont...1)
Abiomed Inc, Annual Ratios (Cont...2)
Abiomed Inc, Interim Ratios
Abiomed Inc, Medical Equipment, Deals By Year, 2015 to YTD 2021
Abiomed Inc, Medical Equipment, Deals By Type, 2015 to YTD 2021
Abiomed Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List Of Figures

LIST OF FIGURES

Abiomed Inc, Performance Chart (2017 - 2021)
Abiomed Inc, Ratio Charts
Abiomed Inc, Medical Equipment, Deals By Year, 2015 to YTD 2021
Abiomed Inc, Medical Equipment, Deals by Type, 2015 to YTD 2021